Multi-institutional oncogenic driver mutation analysis in lung adenocarcinoma: The Lung Cancer Mutation Consortium experience

INTRODUCTION: Molecular genetic analyses of lung adenocarcinoma have recently become standard of care for treatment selection. The Lung Cancer Mutation Consortium was formed to enable collaborative multi-institutional analyses of 10 potential oncogenic driver mutations. Technical aspects of testing,...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Thorac Oncol
Main Authors: Sholl, Lynette M., Aisner, Dara L., Varella-Garcia, Marileila, Berry, Lynne D., Dias-Santagata, Dora, Wistuba, Ignacio I., Chen, Heidi, Fujimoto, Junya, Kugler, Kelly, Franklin, Wilbur A., Iafrate, A. John, Ladanyi, Marc, Kris, Mark G., Johnson, Bruce E., Bunn, Paul A., Minna, John D., Kwiatkowski, David J.
Formato: Artigo
Idioma:Inglês
Publicado: 2015
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4410843/
https://ncbi.nlm.nih.gov/pubmed/25738220
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0000000000000516
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares